Important Information for Investors of Zynex, Inc. (ZYXI)
New York, NY – Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Zynex, Inc. (ZYXI) between March 13, 2023, and March 11, 2025, both dates inclusive (the “Class Period”), of the upcoming May 19, 2025 lead plaintiff deadline.
What Happened?
According to the lawsuit, the defendants during the Class Period made false and/or misleading statements and/or failed to disclose that:
- Zynex’s revenue growth was primarily driven by the sale of its transcranial electrical stimulation (tES) devices, which were subject to reimbursement risks;
- The company’s tES devices faced increased regulatory scrutiny and competition;
- Zynex’s financial statements for the fiscal years 2023 and 2024 contained material misstatements and omissions;
How This Affects You
If you purchased Zynex securities during the Class Period, you may be entitled to compensation without payment of any out-of-pocket fees or costs through a contingency fee arrangement. The process is simple and requires no out-of-pocket costs or expenses. To get more information, you can contact the Rosen Law Firm:
Jordan Schneider, Esq.
325 Broadway, 5th Floor
New York, NY 10013
Tel: (212) 686-1060
Email: [[email protected]](mailto:[email protected])
How This Affects the World
The lawsuit against Zynex, Inc. highlights the importance of transparency and accuracy in financial reporting. Companies must provide clear and truthful information to their investors to maintain trust and confidence in the market. The outcome of this case could set a precedent for other similar cases and send a strong message to companies to prioritize honesty and integrity.
Conclusion
If you believe that you have suffered a loss as a result of the above-mentioned securities fraud, you may be entitled to compensation. Rosen Law Firm encourages you to contact them to discuss your legal options. The firm represents investors worldwide, and there is no cost or obligation to you.
The securities fraud lawsuit against Zynex, Inc. serves as a reminder that investors must remain vigilant and protect their interests. Companies must provide accurate and transparent information to maintain the trust and confidence of the investing public.
For more information, please contact:
Jordan Schneider, Esq.
325 Broadway, 5th Floor
New York, NY 10013
Tel: (212) 686-1060
Email: [[email protected]](mailto:[email protected])
